Drug-induced Valvulopathy: An Update
Tóm tắt
Drug-induced valvulopathy is a serious liability for certain compound classes in development and for some marketed drugs intended for human use. Reports of valvulopathy led to the withdrawal of fenfluramines (anorexigens) and pergolide (antiparkinson drug) from the United States market in 1997 and 2007, respectively. The mechanism responsible for the pathogenesis of valvulopathy by these drugs is likely a result of an “off-target” effect via activation of 5-hydroxytryptamine (5-HT) 2B receptor (5-HT2BR) expressed on heart valve leaflets. Microscopically, the affected valve leaflets showed plaques of proliferative myofibroblasts in an abundant extracellular matrix, composed primarily of glycosaminoglycans. However, the valvular effects caused by fenfluramines and pergolide were not initially predicted from routine preclinical toxicity studies, and to date there are no specific validated animal models or preclinical/toxicologic screens to accurately predict drug-induced valvulopathy. This review covers the structure and function of heart valves and highlights major advances toward understanding the 5-HT2BR-mediated pathogenesis of the lesion and subsequently, development of appropriate animal models using novel techniques/experiments, use of functional screens against 5-HT2BR, and more consistent sampling and pathologic evaluation of valves in preclinical studies that will aid in avoidance of future drug-induced valvulopathy in humans.
Từ khóa
Tài liệu tham khảo
European Medicines Agency (EMEA). (2008). Questions and answers on the review of ergot-derived dopamine agonists. EMEA http://www.emea.europa.eu/pdfs/general/direct/pr/31905408en.pdf
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2005). Annual Report 2005: The State of the Drugs Problem in Europe. EMCDDA http://annualreport.emcdda.eu.int
Fanburg B. L., 1997, Am J Physiol, 272, L795
Fitzgerald L. W., 2000, Mol Pharmacol, 57, 75
Greaves P. (2007). Cardiovascular system. In Histopathology of Preclinical Toxicity Studies – interpretation and relevance in drug safety evaluation (Greaves P. ed.), pp. 270–333. Elsevier, New York.
Hauck A. J., 1990, Arch Pathol Lab Med, 114, 62
Hendrikx M., 1996, J Heart Valve Dis, 5, 235
Keane J. F., 1993, Circulation, 87, 16
Maxie M. G., 2007, Jubb, Kennedy and Palmer’s Pathology of Domestic Animals, 1
Mulholland D. L., 1996, Can J Cardiol, 12, 231
National Toxicology Program (NTP) (1991). NTP Technical Report on the Toxicology and Carcinogenesis Studies of dl-Amphetamine Sulfate (CAS No. 60-13-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP TR-387, NIEHS, Research Triangle Park, NC (http://ntp-server.niehs.nih.gov/index).
Pena-Silva R. A., 2009, Am J Physiol, 297, H1354
Plendl J., 2006, Dellmann’s Textbook of Veterinary Histology, 117
Rajamannan N. M., 2001, J Heart Valve Dis, 10, 827
Roy A., 2000, J Heart Valve Dis, 9, 459
Schoen F. J., 2005, Robbins and Cotran Pathologic Basis of Disease, 555
Schoen F. J., 2001, Cadiovascular Pathology, 402
Taylor P. M., 2000, J Heart Valve Dis, 9, 150
Waltenberger J., 1993, Am J Pathol, 142, 71